Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/FCF ratio is N/A as of 2026-10-06T15:27:37.276Z.
Calculation as of: 2026-10-06T15:27:37.276Z.
Quote observation: 2026-10-06T15:24:27.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 15f4d798ccf4875796eb71b515450313e327808a34ea0284d87d2ac67ba5f97e
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
N/A
Market Cap
$7.31M
EV/FCF Ratio
N/A
TTM Avg
41004.37x
3Y Avg
41004.37x
5Y Avg
41004.37x
Market Cap
$7.24M
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Longeveron Inc. (LGVN) | $7.43M | N/A | N/A | N/A | N/A |
| InMed Pharmaceuticals Inc. (INM)vs › | $7.31M | N/A | 41004.37x | 41004.37x | 41004.37x |
| KALA BIO, Inc. (KALA)vs › | $7.28M | N/A | N/A | N/A | N/A |
| Curanex Pharmaceuticals Inc Common Stock (CURX)vs › | $7.24M | N/A | N/A | N/A | N/A |
| Co-Diagnostics, Inc. (CODX)vs › | $7.13M | N/A | 1.99x | 10.75x | 10.75x |
| NeuroSense Therapeutics Ltd. (NRSN)vs › | $7.02M | N/A | N/A | N/A | N/A |
| CNS Pharmaceuticals, Inc. (CNSP)vs › | $7.86M | N/A | N/A | N/A | N/A |
| Mangoceuticals, Inc. (MGRX)vs › | $6.98M | N/A | N/A | N/A | N/A |
| HeartSciences Inc. (HSCS)vs › | $7.90M | N/A | N/A | N/A | N/A |
| GT Biopharma, Inc. (GTBP)vs › | $7.97M | N/A | N/A | N/A | N/A |
EV/FCF
N/A
P/FCF
N/A
FCF Yield
N/A
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
